Skip to content

Pfizer cut to sell by Citi, target to $31

May 17, 2017

Citi downgraded Pfizer (NYSE: PFE) from Neutral to Sell with a price target of $31.00 (from $38.00).

Analyst Andrew Baum said the company needs a deal to deliver on consensus EPS. The firm cut non-GAAP EPS estimates by 5%-10% (2018-22), and their non-GAAP EPS estimates are now 12% below consensus in 2022.

http://bit.ly/2reYgZp

Advertisements

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

You are commenting using your WordPress.com account. ( Log Out / Change )

Twitter picture

You are commenting using your Twitter account. ( Log Out / Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out / Change )

Google+ photo

You are commenting using your Google+ account. ( Log Out / Change )

Cancel

Connecting to %s

«
»
%d bloggers like this: